Abstract:Objectives: This study was aimed to compare the properties of [Tc-99m( PNP5)(DBODC)](+) with Tc-99m-MIBI in normal swine and in canine models of myocardial ischemia. Methods: Seven anesthetized swine were injected intravenously with [Tc-99m(PNP5)(DBODC)] (+). Serial planar images were acquired meanwhile. Twelve adult dogs were studied. A critical stenosis of left anterior descending artery was produced. [Tc-99m(PNP5)( DBODC)] (+) or Tc-99m-MIBI (randomly) was injected intravenously at the end of 3 min of adenosine infusion. The occluder was released after adenosine infusion. Myocardial SPECT imaging was obtained at 30, 60, 90 and 180 min, respectively, after tracer injection. Rest myocardial SPECT imaging was acquired on the next day. Results: Blood disappearance of [(99m) Tc(PNP5)(DBODC)](+) was biexponential with an initial half-time of 2.97 +/- 0.48 min and a late half-time of 52.49 +/- 19.49 min. Myocardial [Tc-99m( PNP5)(DBODC)](+) uptake was similar to Tc-99m-MIBI. Heart-to-liver ratio of [Tc-99m(PNP5)(DBODC)](+) was significantly higher than that of Tc-99m-MIBI (0.99 +/- 0.03 vs. 0.46 +/- 0.10, p < 0.05) 30 min after injection. In canine models of myocardial ischemia, image quality of [Tc-99m(PNP5)(DBODC)] + was better than Tc-99m-MIBI. Segments with perfusion defects by [Tc-99m(PNP5)(DBODC)](+) was 3.60 +/- 1.52 and 4.25 +/- 0.96 by Tc-99m-MIBI (p = n. s.). Conclusions: [Tc-99m( PNP5)(DBODC)](+) seems to be a promising new myocardial perfusion imaging agent. Copyright (C) 2008 S. Karger AG, Basel

Synthesis and biodistribution of a novel [99mTcN(PNP5)(DMCHDTC)]+ complex as a potential myocardial perfusion imaging agent.

Synthesis And Biodistribution Of A Novel [(Tcn)-Tc-99m(Pnp5)(Dmchdtc)](+) Complex As A Potential Myocardial Perfusion Imaging Agent

[99Mtcn(pnp5)(noet)]+: A Novel Potential Myocardial Perfusion Imaging Agent

Synthesis and biodistribution of 99m TcN(CHIPDTC) 2 as a potential myocardial perfusion imaging agent

Synthesis of a Bis(2,3-Dimethylcyclohexyl-dithiocarbamato)-nitrido 99mtc Complex: A Potential Tracer for Myocardial Imaging

Preparation of 99mTc-nitrido asymmetrical heterocomplex with 4-(cyclohexylpiperazin-1-yl)-dithioformate and its biological evaluation as a potential myocardial imaging agent.

Synthesis and biodistribution of <sup>99m</sup>TcN-isopentyl xanthate as a potential myocardial perfusion imaging agent

Synthesis and biodistribution of 99m TcN-isopentyl xanthate as a potential myocardial perfusion imaging agent

Synthesis, Characterization and Biodistribution of A99mtc Nitrido Complex As a Potential Brain Perfusion Imaging Agent

Novel potential myocardial perfusion imaging agent [99mTcN (PNP5) (NOEt)]+

Preparation and Biodistribution of the 99mTcN-CPDTC Complex as a New Potential Brain Perfusion Imaging Agent

Preparation and Prelminary Biodistribution in Mice of 99Mtcn-Bmpbda for Myocardial Perfusion Imaging

Synthesis and biodistribution of a novel 99m Tc nitrido dithiocarbamate complex containing ether group as a potential myocardial and brain imaging agent

Experimental Study of [99mtc(pnp5) (DBODC)]+ As a New Myocardial Perfusion Imaging Agent.

PREPARATION AND BIODISTRIBUTION IN MICE OF NEW ~(99m)Tc-NITRIDE HETEROCOMPLEXES

Preparation And Biodistribution Of Novel Tc-99m(Co)(3)-Cnr Complexes For Myocardial Imaging

Synthesis and biodistribution of a new 99mTc nitrido complex for cerebral imaging

Synthesis and Biodistribution of a New 99mtc Nitrido Complex for Brain Imaging

Study of Biodistribution Properties of a New Myocardial Imaging Agent 99Tcm-N-DBODC5

Synthesis and Biodistribution of Two Novel 99m Tc Nitrido Dithiocarbamate Complexes Containing Heterocyclic Linkage As Potential Brain Perfusion Imaging Agents

Synthesis of New N2S Ligands, Preparation of 99mtc Complexes and Their Preliminary Biodistribution in Mice